Maximize Your Biomarker Strategy to Ensure Clinical Development Success

Deep scientific expertise, tools and extensive development experience to maximize your biomarker strategy

download brochure
The use of biomarkers in clinical drug development programs is a growing requirement for many disease areas that have shifted from the one-drug-for-all to mechanism-matched clinical trial design. Having a comprehensive biomarker strategy can be crucial to ensuring clinical and commercial success of your product.

Download our biomarker brochure to learn how we can help you:
  • Reduce trial costs 
  • Find the right patients faster
  • Accelerate your time to market using 5 key disciplines, such as flow cytometry, that strengthen your biomarker strategy 
With an end-to-end immuno-oncology solution from discovery to companion diagnostics, we're adept at helping drug developers gain a competitive advantage through custom biomarker strategies.

Contact us today to learn how we can help ensure your success in clinical trials, regulatory approvals and new product launches.
Best Practices for Integrating Biomarkers across the Drug Development Continuum

A roadmap for a successful biomarker strategy

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Fighting Cancer: Biomarkers for Immuno-Oncology Clinical Trials

Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Companion Diagnostic Development: Current trends and recommendations

Read More